Market revenue in 2022 | USD 221.2 million |
Market revenue in 2030 | USD 518.7 million |
Growth rate | 11.2% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polyvinyl Chloride (PVC) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 20.98% in 2024. Horizon Databook has segmented the Brazil biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
Brazil holds significant potential to emerge as a major market for biopharma plastics in the coming years owing to the rising geriatric population and increasing government initiatives & investments in healthcare sector.
Rising adoption of strategies like mergers & acquisitions among major companies in the country has led to the creation of consolidated platforms across different segments of the biopharma plastics sector.
Public-private partnerships in healthcare sector aimed at attracting investments and improving overall healthcare infrastructure are expected to positively impact the biopharma plastics market growth in Brazil over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account